NEW YORK (GenomeWeb News) — Beckman Coulter today said it has pocketed $600 million after it placed $525 million in convertible senior notes and after initial buyers decided to exercise their option to purchase $75 million more.
 
Beckman Coulter said it plans to use the cash to pay debts and to increase R&D spending, including developing a molecular diagnostics project. It announced the original $525 million offering on Monday.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.